Abstracts

MONOCYTE ACTIVATION AND CARDIAC-MRI–DERIVED VASCULAR DYSFUNCTION AMONG WOMEN WITH HIV

Women with HIV (WHIV) on ART face an increased risk of cardiovascular disease (CVD), including heart failure. Aortic vascular dysfunction, reflected by increased aortic pulse wave velocity (aPWV), presages, predicts, and promotes adverse CVD outcomes. Moreover, aortic vascular dysfunction –  a proxy for vascular aging – is highly influenced by the local inflammatory milieu. Comparisons…

CAROTID PLAQUE BURDEN IN HIV IS ASSOCIATED WITH SOLUBLE MEDIATORS AND MONOCYTES

Maximal carotid plaque thickness (MCPT) is the measure of the largest plaque thickness in the carotid artery and reflects atherosclerotic plaque burden. MCPT may be a better predictor of cardiovascular disease (CVD) and cerebral vascular accidents (CVA) than cIMT because it identifies potential unstable arterial atherosclerotic plaques. We assessed relationships of monocyte (MO) and T-cell…

INCREASED LEUKOCYTE/PLATELET INTERPLAY WITH ENDOTHELIUM IN ABC-TREATED HIV PATIENTS

Abacavir (ABC) has been associated with a risk of myocardial infarction. We have demonstrated experimentally that clinical concentrations of ABC added in vitro, but not of tenofovir disopropil fumarate (TDF), have pro-inflammatory (it induces leukocyte-endothelium interactions) and pro-thrombotic (it causes the interplay of platelets with endothelial cells or leukocytes) actions. Furthermore, ABC promoted thrombus formation…

HOST GLYCOMIC DETERMINANTS OF CORONARY ATHEROSCLEROSIS DURING TREATED HIV INFECTION

HIV-induced inflammation is associated with accelerated atherosclerosis, even after virally suppressive antiretroviral therapy (ART). In the general population, host glycomic alterations, in particular, loss of galactose and sialic acid on circulating glycoproteins (including IgG) drive inflammation and are associated with premature aging. Whether glycomic alterations contribute to the development of coronary atherosclerosis during HIV infection…